MITOCHONDRIAL DYSFUNCTION IN T CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

REFERENCES

• K.B., Elkon. Apoptosis in SLE—too little or too much?. Clin. Exper. Rheum.. 12: 553–559, 1994, [CSA]
   PubMed Web of Science ®Google Scholar
• A., Perl, K., Banki. Molecular mimicry altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus. G.M., Kammer, G.C., Tsokos. Lupus Molecular and Cellular Pathogenesis. Totowa, NJ, Humana Press. 43–64, 1999
   Google Scholar
• J.J., Cohen, R.C., Duke, V.A., Fadok, K.S., Sellins. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol.. 10: 267–293, 1992, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.B., Thompson. Apoptosis in the pathogenesis and treatment of disease. Science. 267: 1456–1462, 1995
   PubMed Web of Science ®Google Scholar
• W., Emlen, J.A., Niebur, R., Kadera. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol.. 152: 3685–3692, 1994
   PubMed Web of Science ®Google Scholar
• L.A., Casciola-Rosen, G., Anhalt, A., Rosen. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med.. 179: 1317–1330, 1994, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• B., Kovacs, D., Vassilopoulos, S.A., Vogelgesang, G.C., Tsokos. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha. Clin. Immunol. Immunopathol.. 81: 293–302, 1996, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Lenardo, K.M., Chan, F., Hornung, H., McFarland, R., Siegel, J., Wang. Mature T lymphocyte apoptosis—immune regulation in a dynamic and unpredictable antigenic environment. Ann. Rev. Immunol.. 17: 221–253, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V.P., Skulachev. Mitochondrial physiology and pathology; Concepts of programmed death of organelles, cells and organisms. Mol Aspects Med.. 20: 139–140, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• J., Xiang, D.T., Chao, S.J., Korsmeyer. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93: 14559–14563, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.A., Susin, N., Zamzami, M., Castedo, E., Daugas, H.-G., Wang, S., Geley. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J Exp. Med.. 186: 25–37, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Vander Heiden, N.S., Chandel, E.K., Williamson, P.T., Schumaker, C.B., Thompson. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91: 627–637, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P., Constantini, B.V., Chernyak, V., Petronilli, P., Bernardi. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem.. 271: 6746–6751, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.A., Mayes. The pentose phosphate pathway & other pathways of hexose metabolism. R.K., Murray, D.K., Granner, P.A., Mayes, V.W., Rodwell. Harper's Biochemistry. Norwalk, CT, Appleton & Lange. 201–211, 1993
   Google Scholar
• K., Banki, E., Hutter, E., Colombo, N.J., Gonchoroff, A., Perl. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem.. 271: 32994–33001, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K., Banki, E., Hutter, N., Gonchoroff, A., Perl. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol.. 162: 1466–1479, 1999
   PubMed Web of Science ®Google Scholar
• S.A., Lipton, Y.-B., Choi, Z.-H., Pan, S.Z., Lei, H.-S.V., Chen, N.J., Sucher. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364: 626–631, 1993, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• B., Halliwell, J.M., Gutteridge. Role of free radicals and catalytic metal ions in human disease: An overview. Meth. Enzymol.. 186: 1–85, 1990
   PubMed Web of Science ®Google Scholar
• J.S., Stamler. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell. 78: 931–936, 1994, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.J., Korsmeyer. Regulators of cell death. Trends Genet.. 11: 101–105, 1995, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T.M., Buttke, P.A., Sandstrom. Oxidative stress as a mediator or apoptosis. Immunol. Today. 15: 7–10, 1994, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• D.L., Hamilos, H.J., Wedner. The role of glutathione in lymphocyte activation. 1. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene- 1-one by nuclear size transformation. J. Immunol.. 135: 2740–2747, 1985
   PubMed Web of Science ®Google Scholar
• M., Los, W., Droge, K., Stricker, P.A., Bauerle, K., Schulze-Osthoff. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol.. 25: 159–165, 1995, [CSA]
   PubMed Web of Science ®Google Scholar
• A., Perl, K., Banki. Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antiox. Redox. Signal.. 2: 551–573, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Suthanthiran, M.E., Anderson, V.K., Sharma, A., Meister. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA. 87: 3343–3347, 1990, [CSA]
   PubMed Web of Science ®Google Scholar
• G.A., Koretzky, N.J., Boerth. The role of adapter proteins in T cell activation. Cell. Mol. Life Sci.. 56: 1048–1060, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Otsuji, Y., Kimura, T., Aoe, Y., Okamoto, T., Saito. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA. 93: 13119–13124, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.I., Gringhuis, A., Leow, E.A., Papendrecht-Van Der Voort, P.H., Remans, F.C., Breedveld. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J. Immunol.. 164: 2170–2179, 2000
   PubMed Web of Science ®Google Scholar
• R., Gopalakrishna, S., Jaken. Protein kinase C signaling and oxidative stress. Free Radical Biol. Med.. 28: 1349–1361, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Lucas, V., Sanchez-Margalet. Protein kinase C involvement in apoptosis. Gen. Pharmac.. 26: 881–887, 1995, [CSA]
   PubMedGoogle Scholar
• L., Beiqing, M., Chen, R.L., Whisler. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. J. Immunol.. 157: 160–169, 1996
   PubMed Web of Science ®Google Scholar
• K., Furuke, M., Shiraishi, H.S., Mostowski, E.T., Bloom. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol.. 162: 1988–1993, 1999
   PubMedGoogle Scholar
• S., Saccani, A., Saccani, L., Varesio, P., Ghosh, H.A., Young, A., Sica. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur. J. Immunol.. 29: 1194–1201, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• J., Abe, B.C., Berk. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J. Biol. Chem.. 274: 21003–21010, 1999, [CROSSREF]
   PubMedGoogle Scholar
• J., Abe, M., Takahashi, M., Ishida. J.D. Lee, and B.C. Berk, c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase I. J Biol. Chem.. 272: 20389–20394, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.A., Deora, T., Win, B., Vanhaesebroeck, H.M., Lander. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem.. 273: 29923–29928, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.P., Hehner, R., Breitkreutz, G., Shubinsky, H., Unsoeld, K., Schulze-Osthoff, M.L., Schmitz. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol.. 165: 4319–4328, 2000
   PubMed Web of Science ®Google Scholar
• M., Yoshizumi, J., Abe, J., Haendeler, Q., Huang, B.C., Berk. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem.. 275: 11706–11712, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S., Qin, T., Inazu, M., Takata, T., Kurosaki, Y., Homma, H., Yamamura. Cooperation of tyrosine kinases p72syk and p53/56lyn regulates calcium mobilization in chicken B cell oxidant stress signaling. Eur. J. Biochem.. 236: 443–449, 1996, [CROSSREF]
   PubMedGoogle Scholar
• M.E., Ginn-Pease, R.L., Whisler. Redox signals and NF-kappaB activation in T cells. Free Radical Biol. Med.. 25: 346–361, 1998, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H., Nakamura, K., Nakamura, J., Yodoi. Redox regulation of cellular activation. Ann. Rev. Immunol.. 15: 351–369, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W.N., Tian, L.D., Braunstein, J., Pang, K.M., Stuhlmeier, Q.C., Xi, R.C., Stanton. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem.. 273: 10609–10617, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K., Banki, E., Hutter, N.J., Gonchoroff, A., Perl. Molecular ordering in HIV-induced apoptosis: Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J Biol. Chem.. 273: 11944–11953, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.V., Ursini, A., Parrella, G., Rosa, S., Salzano, G., Martini. Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem. J.. 323: 801–806, 1997
   PubMed Web of Science ®Google Scholar
• J., Piette, B., Piret, G., Bonizzi, S., Schoonbroodt, M.P., Merville, S., Legrand-Poels. Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem.. 378: 1237–1245, 1997, [CSA]
   PubMed Web of Science ®Google Scholar
• V., Imbert, R.A., Rupec, A., Livolsi, H.L., Pahl, E.B., Traenckner, C., Mueller-Dieckmann. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell. 86: 787–798, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K.N., Schmidt, P., Amstad, P., Cerutti, P.A., Baeuerle. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem. Biol.. 2: 13–22, 1995, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.B., Traenckner, P.A., Baeuerle. Appearance of apparently ubiquitin- conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells. J. Cell Sci.-Suppl.. 19: 79–84, 1995, [CSA]
   PubMedGoogle Scholar
• N., Li, N., Karin. Is NF-kB the sensor of oxidative stress?. FASEB J.. 13: 1137–1143, 1999, [CSA]
   PubMed Web of Science ®Google Scholar
• C., Kretz-Remy, E.E., Bates, A.P., Arrigo. Amino acid analogs activate NF- kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-I long terminal repeat activation. J. Biol. Chem.. 273: 3180–3191, 1998, [CROSSREF]
   PubMedGoogle Scholar
• T., Okamoto, H., Ogiwara, T., Hayashi, A., Mitsui, T., Kawabe, J., Yodoi. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type I by thiol redox control mechanism. Internat. Immunol.. 4: 811–819, 1992
   PubMed Web of Science ®Google Scholar
• T., Hayashi, Y., Ueno, T., Okamoto. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem.. 268: 11380–11388, 1993
   PubMed Web of Science ®Google Scholar
• W., Droge, K., Schulze-Osthoff, S., Mihm, D., Galter, H., Schenk, H.P., Eck. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J.. 8: 1131–1138, 1994, [CSA]
   PubMed Web of Science ®Google Scholar
• T., Okamoto, S., Sakurada, J.P., Yang, J.P., Merin. Regulation of NF-kappa B and disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr. Topics Cell. Regulation. 35: 149–161, 1997, [CSA]
   PubMedGoogle Scholar
• J.R., Matthews, N., Wakasugi, J.L., Virelizier, J., Yodoi, R.T., Hay. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucl. Acids. Res.. 20: 3821–3830, 1992
   PubMed Web of Science ®Google Scholar
• D., Galter, S., Mihm, W., Droge. Distinct effects of glutathione disulphide on the transcription factors NFkB and AP-1. Eur. J. Biochem.. 221: 639–648, 1994, [CROSSREF]
   PubMedGoogle Scholar
• S., Nagata. Apoptosis by death factor. Cell. 88: 355–365, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N., Itoh, S., Nagata. A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen. J. Biol. Chem.. 268: 10932–10937, 1993
   PubMed Web of Science ®Google Scholar
• L.A., Tartaglia, T.M., Ayres, G.H.W., Wong, G.V., Goeddel. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74: 845–853, 1993, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Tewari, V.M., Dixit. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the Poxvirus crmA gene product. J. Biol. Chem.. 270: 3255–3260, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Los, M., Van de Craen, L.S., Penning, H., Schenk, M., Westendorp, P.A., Baeuerle. Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature. 375: 81–83, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Enari, H., Hug, S., Nagata. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375: 78–81, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.J., Martin, D.R., Green. Protease activation during apoptosis: death by a thousand cuts. Cell. 82: 349–352, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.P., Boldin, T.M., Goncharov, Y.V., Goltsev, D., Wallach. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1- and TNF receptor-induced cell death. Cell. 85: 803–815, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Muzio, A.M., Chinnaiyan, F.C., Kischkel, K., O'Rourke, A., Shevchenko, J., Ni. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 [Fas/Apo1] death-inducing signaling complex. Cell. 85: 817–827, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Thome, P., Schneider, K., Hofman, H., Fickenscher, E., Meinl, F., Neipel. Viral FLICE-inhibitory proteins [FLIPs] prevent apoptosis induced by death receptors. Nature. 386: 517–521, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., Bertin. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94: 1172–1176, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Algeciras-Schimnich, T.S., Griffith, D.H., Lynch, C.V., Paya. Cell cycle- dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol.. 162: 5205–5211, 1999
   PubMedGoogle Scholar
• B., Meier, H.H., Radeke, S., Selle, M., Younes, H., Sies, K., Resch. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem. J.. 263: 539–545, 1989, [CSA]
   PubMed Web of Science ®Google Scholar
• T., Hennet, C., Richter, E., Peterhans. Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J.. 289: 587–592, 1993
   PubMed Web of Science ®Google Scholar
• K., Schulze-Osthoff, P.H., Krammer, W., Droge. Divergent signaling via APO-1/Fas and the TNFreceptor, two homologous molecules involved in physiological cell death. EMBO J.. 13: 4587–4596, 1994, [CSA]
   PubMed Web of Science ®Google Scholar
• Y., Kasahara, K., Iwai, A., Yachie, K., Ohta, A., Konno, H., Seki. Involvement of reactive oxygen intermediates in spontaneous and CD95 [Fas/APO–1]-mediated apoptosis of neutrophils. Blood. 89: 1748–1753, 1997, [CSA]
   PubMed Web of Science ®Google Scholar
• M.S., Williams, P.A., Henkart. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol.. 157: 2395–2402, 1996
   PubMed Web of Science ®Google Scholar
• E., Gulbins, B., Brenner, K., Schlottmann, J., Welsch, H., Heinle, U.L., Koppenhoefer. Fas-induced programmed cell death is mediated by a Ras-regulated O2- synthesis. Immunology. 89: 205–212, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H.D., Um, J.M., Orenstein, S.M., Wahl. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J. Immunol.. 156: 3469–3477, 1996
   PubMed Web of Science ®Google Scholar
• F., Puskas, P., Gergely, K., Banki, A., Perl. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J.. 14: 1352–1361, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.-F., Li, R., Dietz, R., von. Harsdorf, p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by bcl-2. EMBO J.. 18: 6027–6036, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E., Gottlieb, M.G., Vander Heiden, C.B., Thompson. Bcl-XL prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell. Biol.. 20: 5680–5689, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.L., Scarlett, P.W., Sheard, G., Hughes, E.C., Ledgerwood, H.-H., Ku, M.P., Murphy. Changes in mitochondrial membrane potential during staurosporin-induced apoptosis in Jurkat cells. FEBS Lett.. 475: 267–272, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G.S., Salvesen, V.M., Dixit. Caspases: Intracellular signaling by proteolysis. Cell. 91: 443–446, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Gross, J.M., McDonnell, S.J., Korsmeyer. BCL-2 family members and the mitochondria in apoptosis. Genes Dev.. 13: 1899–1911, 1999
   PubMed Web of Science ®Google Scholar
• P.J., Gergely, C., Grossman, B., Niland, F., Puskas, H., Neupane, F., Allam. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arth. Rheum.. 46: 175–190, 2001
   Google Scholar
• P.J., Gergely, B., Niland, N., Gonchoroff, R., Pullmann. Jr.  P.E. Phillips, and A. Perl. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol.. 169: 1092–1101, 2002
   PubMed Web of Science ®Google Scholar
• L., Stryer. Biochemistry 3rd. New York, W.H. Freeman and Company. 1988
   Google Scholar
• P., Li, D., Nijhawan, I., Budihardjo, S.M., Srinivasula, M., Ahmad, E.S., Alnemri. Cytochrome c and dATP-depedent formation of Apaf-1/Caspase-9 complex initiates and apoptotic protease cascade. Cell. 91: 479–489, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Barkett, D., Xue. H.R. Horvitz, and T.D. Gilmore. Phosphorylation of IkB-α inhibits its cleavage by caspase CPP32 in vitro. J Biol. Chem.. 272: 29419–29422, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y., Emoto, Y., Manome, G., Meinhardt, H., Kisaki, S., Kharbanda, M., Robertson. Proteolytic activation of protein kinase C d by an ICE-like protease in apoptotic cells. EMBO J.. 14: 6148–6156, 1995, [CSA]
   PubMed Web of Science ®Google Scholar
• R., Datta, H., Kojima, K., Yoshida, D., Kufe. Caspase-3-mediated cleavage of protein kinase C O in induction of apoptosis. J. Biol. Chem.. 272: 20317–20320, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Enari, H., Sakahira, H., Yokoyama, K., Okawa, A., Iwamatsu, S., Nagata. A capase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391: 43–50, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D.R., Green, J.C., Reed. Mitochondria and apoptosis. Science. 281: 1309–1312, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H., Harada, B., Becknell, M., Wilm, M., Mann, L.J., Huang, S.S., Taylor. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3: 413–422, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., Yang, X., Liu, K., Bhalla, C.N., Kim, A.M., Ibrado, J., Cai. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275: 1129–1132, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.M., Kluck, E., Bossy-Wetzel, D.R., Green, D.D., Newmeyer. The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis. Science. 275: 1132–1136, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Leist, B., Single, A.F., Castoldi, S., Kuhnle, P., Nicotera. Intracellular adenosine triphosphate [ATP] concentration: A switch in the decision between apoptosis and necrosis. J Exp. Med.. 185: 1481–1486, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y., Lee, E., Shacter. Oxidative stress inhibits apoptosis in human lymphoma cells. J. Biol. Chem.. 274: 19792–19798, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.C., Chow, G.E.N., Kass, S., Orrenius. Purine and their role in apoptosis. Neuropharmacology. 36: 1149–1156, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.S., Lewis. Calcium signaling mechanisms in T lymphocytes. Ann. Rev. Immunol.. 19: 497–521, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K.F., LaNoue, J., Duszynski. Kinetic studies of ATP synthase: the case for the positional change mechanism. J. Bioenergetics Biomembranes. 24: 499–506, 1999, [CSA]
   Google Scholar
• D.J., McConkey, S., Orrenius. The role of calcium in the regulation of apoptosis. J. Leukocyte Biol.. 59: 775–783, 1996, [CSA]
   PubMed Web of Science ®Google Scholar
• S., Nagata, P., Golstein. The Fas death factor. Science. 267: 1449–1456, 1995
   PubMed Web of Science ®Google Scholar
• G.H., Fisher, F.J., Rosenberg, S.E., Straus, J.K., Dale, L.A., Middleton, A.Y., Lin. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81: 935–946, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., Drappa, A.K., Vaishnaw, K.E., Sullivan, J.-L., Chu, K.B., Elkon. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl. J. Med.. 335: 1643–1649, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F., Salvemini, A., Franze, A., Iervolino, S., Filosa, S., Salzano, M.V., Ursini. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J. Biol. Chem.. 274: 2750–2757, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O., Le Moine, H., Louis, P., Stordeur, J.M., Collet, M., Goldman, J., Deviere. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology. 113: 1701–1706, 1997
   Google Scholar
• M., al Janadi, S., al Balla, A., al Dalaan, S., Raziuddin. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol.. 13: 58–67, 1993, [CROSSREF]
   PubMedGoogle Scholar
• A., Studnicka-Benke, G., Steiner, P., Petera, J.S., Smolen. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Brit. J. Rheum.. 35: 1067–1074, 1996, [CSA]
   PubMedGoogle Scholar
• A.J., Swaak. H.G. van den Brink, and L.A. Aarden, Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J. Rheum.. 25: 233–238, 1996
   PubMed Web of Science ®Google Scholar
• B.S., Handwerger, I., Luzina, L., Da Silva, C.E., Storrer, C.S., Via. Cytokines in the immunopathogenesis of lupus. G.S., Kammer, G.C., Tsokos. Lupus Molecular and cellular pathogenesis. Totowa, NJ, Humana. 321–340, 1999
   Google Scholar
• S.N., Liossis, X.Z., Ding, G.J., Dennis, G.C., Tsokos. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest.. 101: 1448–1457, 1998, [CSA]
   PubMed Web of Science ®Google Scholar
• D., Li, B., Yang, J.L., Mehta. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC PTK, bcl-2, and Fas. Am. J. Physiol.. 275: H568–H576, 1998
   PubMedGoogle Scholar
• J.R., Orlinick, A., Vaishnaw, K.B., Elkon, M.V., Chao. Requirement of cysteine-rich repeats of the Fas receptor for binding of the Fas ligand. J. Biol. Chem.. 272: 28889–28894, 1997, [CROSSREF]
   PubMedGoogle Scholar
• M., Bennett, K., Macdonald, S-W., Chan, J.P., Luzio, R., Simari, P., Weissberg. Cell surface trafficking of Fas A rapid mechanism of p53-induced apoptosis. Science. 282: 290–293, 1998
   Google Scholar
• S., Kasibhatla, L., Genestier, D.R., Green. Regulation of Fas ligand expression during activation-induced cell death in T lymphocytes. J. Biol. Chem.. 274: 987–992, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., He, S., Choe, R., Walker, P., Di. Marzio, D.O. Morgan, and N.R. Landau, Human immunodeficiency virus type 1 viral protein R [vpr] arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol.. 69: 6705–6711, 1995, [CSA]
   PubMed Web of Science ®Google Scholar
• H.M., Lorenz, M., Grunke, T., Hieronymus, M., Herrmann, A., Kuhnel, B., Manger. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arth. Rheum.. 40: 306–317, 1997
   PubMed Web of Science ®Google Scholar
• L., Georgescu, R.K., Vakkalanka, K.B., Elkon, M.K., Crow. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest.. 100: 2622–2633, 1997, [CSA]
   PubMed Web of Science ®Google Scholar
• J.C., Oates, E.F., Christensen, C.M., Reilly, S.E., Self, G.S., Gilkeson. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity. Proc. Assoc. Am. Phys.. 111: 611–621, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• G.S., Cooper, M.A., Dooley, E.L., Treadwell, E.W., St.Clair, C.G., Parks, G.S., Gilkeson. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arth. Rheum.. 41: 1714–1724, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W., Fiers, R., Beyaert, W., Declercq, P., Vandenabeele. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 18: 7719–7730, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• I., Lorand-Metze, M.A., Carvalho, L.T., Costallat. Morphology of bone marrow in systemic lupus erythematosus. Pathologe. 15: 292–296, 1994 (in German), [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Y.H., Ko, J., Dal Lee. Fine needle aspiration cytology in lupus lymphadenopathy. A case report. Acta Cytologica. 36: 748–751, 1992
   PubMedGoogle Scholar
• M.D., Eisner, J., Amory, B., Mullaney, L., Tierney, Jr., W.S., Browner. Necrotizing lymphadenitis associated with systemic lupus erythematosus. Seminars Arth. Rheum.. 26: 477–482, 1996, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• K., Virdee, P.A., Parone, A.M., Tolkovsky. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Bio.. 10: 1151–1154, 2000, [CROSSREF]
   PubMedGoogle Scholar
• B.R., Lauwerys, N., Garot, J.C., Renauld, F.A., Houssiau. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arth. Rheum.. 43: 1976–1981, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K., Ohtsuka, J.D., Gray, M.M., Stimmler, B., Toro, D.A., Horwitz. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J. Immunol.. 160: 2539–2545, 1998
   PubMed Web of Science ®Google Scholar
• G.C., Tsokos, S.-N.C., Liossis. Immune cell signaling defects in lupus: activation, anergy and death. Immunol. Today. 20: 119–124, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• G.M., Kammer. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arth. Rheum.. 42: 1458–1465, 1999, [CROSSREF]
   PubMedGoogle Scholar
• N., Mishra, I.U., Khan, G.C., Tsokos, G.M., Kammer. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes. J Immunol.. 165: 2830–2840, 2000
   PubMedGoogle Scholar
• J.M., Lizcano, N., Morrice, P., Cohen. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J.. 349: 547–557, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Y., Tan, M.R., Demeter, H., Ruan, M.J., Comb. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem.. 275: 25865–25869, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• X.M., Zhou, Y., Liu, G., Payne, R.J., Lutz, T., Chittenden. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem.. 275: 25046–25051, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C.K., Sen, L., Packer. Antioxidant and redox regulation of gene transcription [see comments]. FASEB J.. 10: 709–720, 1996, [CSA]
   PubMed Web of Science ®Google Scholar
• L., Llorente, W., Zou, Y., Levy, Y., Richaud-Patin, J., Wijdenes, J., Alcocer-Varela. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med.. 181: 839–844, 1995, [CROSSREF]
   PubMed Web of Science ®Google Scholar